Background and purpose: Nonalcoholic fatty liver disease (NAFLD) is known as condition in which fat significantly aggregates in the liver and the use of antioxidants can alleviate its adverse effects. This study was aims to evaluate the effects of carvone on hepatic steatosis and NAFLD by investigation of the lipids in serum and liver.
Introduction onalcoholic fatty liver disease (NAFLD) is known as condition in which fat significantly aggregates in the liver of a patient lack a history of alcohol abuse [1] .
NAFLD is grouped into two groups including simple steatosis an Günther et al., nonalcoholic steatohepatitis (NASH). Under NASH condition, steatosis, intralobular inflammation and hepatocellular are found in the progressive fibrosis [2] . Permanent NASH may be caused to liver cirrhosis, and hepatocellular carcinoma [3] [4] [5] .
NAFLD not only increases risk for developing liver disease but is also one key component for metabolic syndrome, obesity, and type 2 diabetes [6] . NAFLD encompasses a broad range including simple fatty liver (intracellular lipids >5%) up to progressive NASH which is accompanied with lobular inflammation, fibrosis, and cirrhosis and increases the risk for hepatocellular carcinoma [7] . Increased aggregation of the triglycerides in hepatocytes is the indicator for NAFLD, which is severely related with hepatic insulin resistance [8] . Increased formation of the triglyceride is observed in fatty livers that are accompanied with obesity and type 2 diabetes mellitus [9] . Hepatic fat aggregation causes to hepatic insulin resistance through promoting gluconeogenesis and activation of the PKC-ε and JNK1signaling pathways [10] . It is not approved agents available for treatment of NAFLD. Improvement of some factors such as weight reduction and dietary fat intake, are usually known as treatment modalities in NAFLD disease [11] .
Studies showed that insulin sensitizers, such as thiazolidinediones, and some antioxidants could improve clinical conditions of NASH [12, 13] . 
Results
Effects of different levels of carvone on liver and body weight are shown in Figure 1 . Results showed that rats in HF group showed higher body weight and liver weight in comparison to control group (P<0.05). Rats fed with HF diets containing 50 and 100 mg/kg carvone showed lower weights in comparison to HF group (P<0.05). Following the induction of hepatic steatosis, liver weight and the serum concentrations of triglycerides and TBARS were significantly higher in HF group in comparison to control group (P<0.05) ( 
Discussion
With regards to previous studies, animals fed with HF diets (50-75% calories derived from fat), 60% in the current present, progress hepaticsteatosis and signs of initial NASH related with dyslipidemia, insulin resistance and changes in mitochondria which result in the increased oxidative stress [19] [20] [21] . However, HF diets cannot significantly develop severe steatohepatitis, but its pathophysiology resembles with human NAFLD [19] [20] [21] . The HF dietinduced NAFLD model is commonly used to evaluate the pathogenesis of NAFLD and in order to find the treatment strategies [22] [23] [24] . However, the use of carvone could alleviate the adverse effects of NAFLD.
In addition to investigation of the steatosis, we also showed that carvone can regress of the preexisting steatosis, which could be found in the clinical conditions in the humans. Our results show that Downloaded from gmjpress.de at 20:11 +0430 on Saturday April 4th 2020 64 81 Carvone Prevents and Alleviates Hepatic Steatosis 122 supplementation with carvone regresses of preexisting hepatic steatosis as assessed by biochemical liver triglyceride contents. Results also showed that carvone could significantly reduce body and liver weights. With regards to previous studies, it is also recommended to use of the treatment strategies for weight loss which improve hepatic steatosis [25] [26] [27] [28] . In summary, carvone reduced the levels of cholesterol and triglycerides in the liver. It could be stated that the decreased both triglycerides and cholesterol in liver causes to increase the liver weight and reduced lipids may be the reason for reduction in liver weight. Since the both levels of carvone could improve the parameters and similar effects were observed in the both groups, it is possible that carvone in the lower doses can inhibit hepatic steatosis. We believe that carvone improves levels of triglycerides and cholesterol by antioxidant 
